Carol Workman
Internal Medicine · Vancouver, WANPI 1366490138
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 280 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,801 and has fallen 69.4% since, to $551 in 2025. Among internal medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 280 payments — averaging $20.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sientra, Inc.$1K
- Kowa Pharmaceuticals America, Inc.$821
- AbbVie$562
- Amarin Pharma, Inc.$467
- AstraZeneca$414
- Amgen$379
- plus $2K from 15 others
What the payments were for
- Food & beverage$5,665100%
- Education$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sientra, Inc. | 15 | $1,330 |
| Kowa Pharmaceuticals America, Inc. | 53 | $821 |
| AbbVie(2 entities) | 27 | $562 |
| Amarin Pharma, Inc. | 48 | $467 |
| AstraZeneca | 15 | $414 |
| Amgen | 24 | $379 |
| Boehringer Ingelheim | 25 | $302 |
| Mentor Worldwide LLC | 7 | $261 |
| BD | 2 | $250 |
| Johnson & Johnson | 5 | $209 |
| Teva Pharmaceuticals USA, Inc. | 6 | $161 |
| Novo Nordisk | 14 | $143 |
| Supernus Pharmaceuticals, Inc. | 24 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $73 |
| Astellas Pharma US Inc | 1 | $64 |
| Davol Inc. | 1 | $49 |
| Biohaven Pharmaceuticals, Inc. | 2 | $27 |
| Lilly USA, LLC | 1 | $12 |
| Pfizer | 1 | $12 |
| Daiichi Sankyo Inc. | 1 | $11 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,690 in reported general payments places this provider in the 95th percentile of 2,038 internal medicine providers in Washington.
Other internal medicine in Vancouver
- Nicholas CarulliVancouver$8K
- Stanley SugarmanVancouver$7K
- Katalin WolfordVancouver$6K
- Peter ShalitSeattle$1M
- Lawrence LoebBellevue$784K
- Shawna PurcellOlympia$294K
- Scott RamseySeattle$230K
- Michael CairnsSeattle$144K
- Peiqing QianSeattle$117K
- Alan KellySpokane Valley$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.